NAMA Website Map

The belief that substances addict people is driven by the fact that few people have any real idea of responsibility without considering it to be equivalent to blame.  The whole disease theorys main attraction is that it gets people off the hook.  If their disease make them behave poorly, then they are not to blame. …

Starting Patrol Heading for the bicycle Tom Jensen starts on his daily patrol to search out used syringes left on the streets last night. First Check The yellow jacket marked “Sprøjte Patruljen” lets the community know that they are safe and BF is on the job picking up used syringes and other paraphernalia. A Syringe…

Page One  Page Two  Page Three  Page Four  Page Five  Page Six  Page Seven  NAMA Advocate Index 

Nominations Open for the 2022 Richard Lane/Robert Holden Advocacy Award! NAMA Recovery    AATOD Lane Holden Award    May 1, 2022  |  0 Richard Lane was a long-term heroin user who, upon release from prison in 1967, was instrumental in establishing one of the Nation’s first opioid treatment programs. In 1974, he became the Executive…

Sponsored by American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Saturday, April 12, 2003 Pre-Conference Session  NAMA offers special thanks to Mallinckrodt. We also wish to thank Haworth Press, Vista Pharmaceuticals, Bendiner Labs, NIDA, and CSAT without whose support the first Certified Methadone Advocate (CMA) Training Course would not…

Join Together Online January 21, 2003 While 616 physicians nationwide are now authorized to prescribe buprenorphine, its widespread use is still an issue, the Baltimore Sun reported on January 15. Product availability is the first problem. Despite receiving FDA approval in October, the manufacturer did not ship the product to pharmaceutical warehouses until last week….